carvacrol has been researched along with Leishmaniasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Andrade-Neto, VV; Chandasana, H; Costa, AMB; Derendorf, H; Dolabella, S; Galvão, JG; Kima, PE; Lira, AAM; Nunes, RS; Santos, JS; Santos, RL; Scher, R; Silva, ARST; Torres-Santos, EC | 1 |
1 other study(ies) available for carvacrol and Leishmaniasis
Article | Year |
---|---|
Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Cymenes; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Lipids; Macrophages, Peritoneal; Male; Mice, Inbred BALB C; Nanostructures; Rats, Wistar; THP-1 Cells | 2020 |